Related Experiment Video
Updated: Apr 1, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Corticosteroid induced hyperosmolar hyperglycaemic state and hemiballismus
Krishna Chinthapalli1, Allison Newey2, Martin Krause3
1Department of Neurology , Royal North Shore Hospital , St Leonards, NSW , Australia.
A rare case of hemiballismus, a movement disorder, was observed in an elderly patient shortly after starting corticosteroid treatment for polymyalgia rheumatica. Symptoms improved with diabetes management.
Area of Science:
- Neurology
- Endocrinology
- Pharmacology
Background:
- Corticosteroids, like prednisolone, are commonly used to manage inflammatory conditions such as polymyalgia rheumatica.
- Hyperglycemia, or high blood sugar, can have various neurological manifestations.
- Hemiballismus is a rare hyperkinetic movement disorder characterized by involuntary, violent, and random-seeming movements.
Observation:
- An 89-year-old male presented with new-onset left-sided hemiballismus affecting his face, arm, and leg.
- The patient had recently commenced prednisolone treatment for polymyalgia rheumatica and presented with significant hyperglycemia (glucose 20.2 mmol/l).
Findings:
- Brain imaging revealed a hypointense lesion in the right lentiform nucleus on T2-weighted MRI, a common finding in stroke or metabolic disturbances.
- The patient's hemiballismus symptoms showed marked improvement following the management of his hyperglycemia and diabetes mellitus.
Implications:
- This case suggests a potential, previously unreported, association between corticosteroid use and the development of hemiballismus, possibly mediated by hyperglycemia.
- Highlights the importance of considering metabolic disturbances, particularly hyperglycemia, in the differential diagnosis of new-onset movement disorders in patients on corticosteroids.
- Further research is warranted to explore the potential neurotoxic effects of corticosteroids or steroid-induced hyperglycemia on basal ganglia function.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetes: Symptoms, Diagnosis, and Complications

